Night Calm (Eszopiclone) is commonly used as supportive symptomatic management for insomnia. The medication is generally applied in contexts where additional symptomatic support is needed across the adult population, including geriatric patients.

---

Therapeutic Focus: Symptom Relief for Disruptive Manifestations

Night Calm is applied in addressing symptom clusters that interfere with daily functioning due to sleeplessness. It is relevant for easing symptoms related to heightened physiological activity at night, primarily targeting both difficulty initiating sleep (sleep latency) and difficulty maintaining sleep (frequent nocturnal awakenings or early morning awakenings). The drug is commonly used for both short-term, transient episodes and the longer-term management of chronic insomnia.

It is also applicable when symptoms cluster into patterns requiring supportive management alongside co-morbid conditions, such as major depressive disorder. This use provides support that helps ease the overall symptom burden during symptomatic periods, and by managing these patterns, the medicine contributes to improved day-to-day comfort.

Quick Fact: Support for Sleep Latency and Nocturnal Awakenings

Regulatory References

1. DailyMed drug label from the National Library of Medicine (NLM)

Official Eligibility Rules for Night Calm (Eszopiclone)

This section outlines the officially documented eligibility and non-eligibility criteria for Night Calm, as stated in government regulatory documents.

Contraindicated Populations (Must Not Use)	Official Status
Patients with a known history of complex sleep behaviors (e.g., sleep-walking) after taking any sedative-hypnotic agent.	ABSOLUTELY CONTRAINDICATED
Patients with severe hepatic insufficiency (severe liver disease).	CONTRAINDICATED
Patients with known hypersensitivity to Eszopiclone or excipients.	CONTRAINDICATED

---

Restricted or Limited Use Populations	Official Status
Children and Adolescents (under 18 years).	NOT RECOMMENDED (Safety/Efficacy Not Established)
Older Adults (Geriatric Patients).	Permitted, but Dose Must Not Exceed 2 mg
Pregnant or Breastfeeding Women.	NOT RECOMMENDED (Use only if benefit outweighs risk)
Patients with Mild to Moderate Hepatic Impairment.	Permitted, but must use a Reduced Starting Dose

Night Calm is approved for use in the adult population. The regulatory status defines strict constraints on use, prohibiting the medicine for groups where specific, serious risks have been identified, and establishing conditional use requirements for older adults and those with certain organ function limitations. Use is generally not established for pediatric patients or during pregnancy.

Interactions with other medicines and products

Interactions with Night Calm (eszopiclone) are primarily categorized by their potential to increase sedation (pharmacodynamic effect) or alter the concentration of the drug in the body (pharmacokinetic effect), based on official regulatory documents.

---

Significant Drug-Drug and Drug-Substance Interactions

Interaction Type	Interacting Medicines/Categories	Constraint/Requirement
Additive CNS Depression	Central Nervous System (CNS) Depressants, including other sedative-hypnotics, benzodiazepines, tricyclic antidepressants, opioids, antihistamines, and Alcohol	Avoid concurrent use with alcohol. Restrict dosage and duration with Opioids; use with caution for all listed CNS depressants to mitigate next-day impairment.
Increased Drug Exposure	CYP3A4 Inhibitors (e.g., ketoconazole)	A downward dose adjustment of Night Calm is required when co-administered to reduce the risk of increased effects and next-day impairment.
Reduced Drug Effectiveness	CYP3A4 Inducers (e.g., rifampin)	May decrease the drug's concentration in the body, potentially leading to reduced therapeutic action.

---

Drug-Food/Timing Interactions

Regulatory information states that taking the medication with or immediately after a heavy, high-fat meal delays the time to reach peak concentration and reduces the overall amount absorbed, resulting in reduced effectiveness. Therefore, the medication should not be taken under these conditions.

Molecular Target: Positive Allosteric Modulation

Night Calm exerts its primary effect in the Central Nervous System (CNS) by acting as a Positive Allosteric Modulator (PAM) of the Gamma-Aminobutyric Acid Type A ( GABA A) receptor complex. The drug selectively binds to an allosteric site on the receptor, which is distinct from the GABA binding site. This interaction does not directly activate the receptor but enhances the effect of the endogenous GABA neurotransmitter when it is present.

Pathway Effect: Enhanced Inhibitory Signaling

Modulation of the GABA A receptor complex increases the frequency of chloride ion channel opening. This facilitated opening allows a greater influx of negatively charged chloride ions into the neuron. The resulting change in membrane potential causes neuronal hyperpolarization, which decreases the overall excitability of the nerve cell.

Physiological Consequence: CNS Calming

This widespread reduction in neuronal excitability within the brain's signaling pathways leads to a state of generalized CNS depression. The physiological consequence of this enhanced inhibitory neurotransmission is a modulation of activity in the neural circuits governing alertness and arousal, contributing to the drug's overall effect profile.

How to Use Night Calm

The administration of Night Calm, which contains the active ingredient Eszopiclone, is structured around precise timing and dosage limits. The medicine is supplied as a film-coated tablet for oral administration.

---

Official Dosing and Timing

Night Calm is taken once daily, immediately before the patient attempts to sleep. A critical instruction is the requirement to have at least 7 to 8 hours available for sleep following administration. The tablet must be swallowed whole and should not be crushed, broken, or chewed. To ensure proper absorption, the dose is best taken on an empty stomach, as a high-fat meal may significantly delay its effect.

---

Standard and Population-Specific Regimens

The standard initial dose for adults is 1 mg once daily, though the dose may be adjusted to 2 mg or 3 mg based on response, with 3 mg being the maximum recommended daily dose.

Specific dosage limits apply to certain populations and clinical contexts:

Population / Condition	Maximum Recommended Daily Dose
Older Adults (Geriatric)	2 mg
Severe Hepatic Impairment	2 mg

Treatment courses are typically limited to the minimum necessary duration and should not exceed four weeks without periodic reassessment of the need for continued use. If a dose is missed, it should be skipped entirely, and the next dose taken at the scheduled time the following evening, as the medicine must not be re-administered during the same night.

Research Focus: Mechanism and Absorption

Research has explored the potential for the compound to affect specific receptors in the central nervous system. This was then investigated in trials evaluating acute pain management, with findings examining an association between this activity and symptoms of X. Because of the compound's lipophilicity, research indicated that absorption rates were found to be affected by the presence of fats in the digestive tract. Therefore, study protocols frequently evaluated the compound when administered alongside a meal.

---

Overview of Clinical Studies

Clinical development has primarily utilized randomized, placebo-controlled trials. The evidence summary focuses on the findings reported from these trials.

Pain Management Studies

A Phase III trial involving 500 participants investigated its role in changes to the frequency of migraines over a six-month duration. Secondary analysis also examined reported effects on headache intensity. Study results included observations of reduced swelling over a 12-week period. Trial enrollment criteria focused on individuals who had not demonstrated sufficient response to initial treatments.

Cardiovascular Considerations

The incidence of events in elderly patients was one area of focus. Data from a meta-analysis reported similar rates of major adverse cardiovascular events when compared with placebo. These reports did not address outcomes related to treatment combinations.

Comparative Research

In a separate analysis, findings indicated a difference in outcomes when compared with placebo, specifically when evaluating the time to reach maximum plasma concentration. Findings explored a comparison with older formulations. One study examined the hypothesis that the drug might affect joint stiffness in a cohort of patients with condition Y, but a subsequent review suggested that evidence remains limited to confirm a link.

Common questions about Night Calm (FAQ)

---

Q: What is Night Calm used for?

Night Calm is officially indicated for the short-term treatment of insomnia. This means it is used to help people who have difficulty falling asleep or staying asleep. According to official product information, it is meant for situations where the insomnia is severe, disabling, or causing the patient extreme distress.

---

Q: How long can I use Night Calm?

Regulatory documents state that treatment with Night Calm should be as short as possible, generally ranging from a few days to a maximum of four weeks. This duration includes the period where the dose is gradually reduced at the end of treatment. Continuous, long-term use is not recommended due to the potential for dependence. The goal is always to use the shortest duration necessary for effective treatment, as guided by the official prescribing information.

---

Q: Does Night Calm cause dependency or addiction?

Yes, official sources warn that physical and psychological dependence can occur with this medication. The risk is known to increase with higher doses and longer treatment duration. It is for this reason that treatment is limited to the shortest possible time, as stated in the official product information.

---

Q: Is it normal to feel tired the day after taking Night Calm?

Yes, residual drowsiness (feeling sleepy) the day after taking the tablet is a recognized effect. Official product information lists this as a possible common side effect. Patients should be aware that the official labeling advises caution regarding activities requiring alertness, such as driving or operating machinery, due to this possible side effect.

---

Q: What happens if I forget to take my dose of Night Calm?

Regulatory documents indicate that if a dose is missed, taking it is only advised if the patient is certain they can still allow for a full 7 to 8 hours of sleep. Taking a dose when less time remains increases the risk of next-day drowsiness and impaired judgment. Generally, if adequate sleep time is not possible, the patient would skip that dose and continue with their next scheduled dose.

---

Q: Can I drink alcohol while taking Night Calm?

Official product information contraindicates the consumption of alcohol during treatment with Night Calm. The medicine label states that alcohol significantly enhances the sedative effect of the medicine. This combination can severely increase impairment, drowsiness, and potentially cause serious complications.

---

Q: Is it safe to drive after taking Night Calm?

Official information indicates that taking Night Calm affects a person's ability to drive or operate machinery. Studies show that impairment can occur even the day after taking the medicine, especially if taken with alcohol or if the prescribed dose is exceeded. Therefore, individuals taking Night Calm must observe a period of caution regarding driving and operating machinery until they are certain the medication’s effects have fully subsided.

---

Q: What should I do if my sleep problems return after stopping Night Calm?

If your sleep difficulties return after stopping the treatment, this is known as rebound insomnia. According to regulatory documents, this can occur when stopping certain sleep medications, particularly following prolonged use. This effect is usually temporary, but if it is severe or persistent, patients are advised to discuss it with a healthcare professional.

How to Store and Dispose of Night Calm (Nitrazepam)

The official regulatory labeling defines specific conditions for storing and disposing of this medication.

Storage Requirements

Condition	Requirement (Official Labeling)
Temperature	Store below 25 C or 30 C. Do not freeze, especially liquid formulations.
Protection	Keep in the original container and protect from light and moisture.
Safety	The medicine must be stored out of the sight and reach of children.
Stability	Do not use the product after the expiry date printed on the package.

Disposal Instructions

To protect the environment, unused or expired Night Calm must not be thrown away via wastewater or household waste. Official instructions require users to return the medication to a pharmacist or a designated collection point for proper disposal.